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Abstract 
Porcine Reproductive and Respiratory Syndrome Virus (PRSSV) is one of the most 
economically important diseases in the global swine industry, costing producers an estimated 
$660 million annually. PRRSV is genetically diverse with a low replication fidelity, due to it 
being an RNA virus, resulting in multitudes of isolates being produced. This virus has a tropism 
for cells of the monocyte/macrophage lineage. Cluster of Differentiation 163 (CD163) is 
considered the primary PRRSV receptor located on porcine alveolar macrophages (PAMs). 
CRISPR/Cas9 technology was utilized to knock out CD163 via a frameshift mutation, resulting 
in pigs of the CD163 Null genotype. Also, a domain of porcine CD163 was deleted and replaced 
with the insertion of a CD163 homolog of human-like domain and neomycin cassette to serve as 
a genetic marker. This swap resulted in pigs that possessed a CD163L1 domain 8 mimic of 
porcine homolog human CD163-like (hCD163L-1) of SRCR domain 8. Previous work has 
demonstrated that CD163 Null pigs were resistant to one genotype 2 PRRSV isolate. An in vivo 
study was performed to observe whether hCD163L-1 pigs were also resistant to infection. 
Various diagnostic tests were performed to determine the presence or absence of PRRSV viremia 
levels in serum, CD163 receptor surface expression levels on PAMs, IgG antibody levels and 
haptoglobin (Hp) levels in serum. hCD163L-1 pigs did not support genotype 1 PRRSV 
replication, but were susceptible to genotype 2 PRRSV infections.  In addition, in vitro infection 
experiments were performed on PAMs and macrophages derived from peripheral blood 
mononuclear cells (PBMCs) to determine resistance to multiple isolates. hCD163L-1 
macrophages showed reduced infection with genotype 2 and no infection with genotype 1 
PRRSV during in vitro infections. Null PAMs and PBMCs derived macrophages did not support 
infection towards any isolate of either PRRSV genotype. 
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Chapter 1 - Literature Review of the PRRS Virus, the Macrophage 
Receptor CD163, and Genetic Editing via the CRISPR/Cas9 System 
Introduction 
Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) has plagued the global 
swine industry since the early 1980s. It was first termed Mystery Swine Disease, as it caused a 
variety of clinical signs in pigs. Veterinarians were unable to determine the etiologic agent in the 
United States (Keffaber, 1989), and the syndrome later appeared in Europe. However, the first 
isolate was characterized in 1991 (Benfield et al., 1992). The etiological agent was identified and 
sequenced in Europe in 1991 and called Lelystad virus (Wensvoort et al., 1991). Clinical signs 
ranged from reproductive failure in breeding age females, reduced weight gain and pneumonia in 
post weaning pigs, and increased mortality among all age groups (Hill, 1993). Transmission 
occurs via contact (Willis et al., 1997), boar semen (Yaeger et al., 1993), and as well as through 
fomites such as boots and coveralls (Otake et al., 2002). Annual productivity losses associated 
with PRRSV in the U.S. were estimated to be $660 million in 2011 with 45% of the cost coming 
from losses in the breeding herd (Holtkamp et al. 2011; Neumann et al., 2005).  
Many to combat PRRSV have focused on vaccine development and selective mating of 
potential PRRSV tolerance in pigs. Both modified-live virus (MLV) and killed vaccines have 
been evaluated for efficacy and protection against PRRSV. MLV vaccines have been shown to 
provide heterologous protection against respiratory disease associated with PRRSV over killed 
autogenous vaccines (Roof et al., 1999). More recently, a MLV vaccine was shown to reduce 
viremia levels, PRRSV-induced lesions, and decrease nasal shedding of virus from challenged 
pigs (Park et al., 2014). However, most vaccines on the market are not completely effective at 
eliminating virus replication, as different responses of vaccinated animals have been observed.  
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Certain genotypes of pigs from various genetic lines have been observed to show a production of 
PRRSV-neutralizing antibodies (NA) against isolates as well as better growth and performance 
in mass infection studies (Rowland et al., 2012). Nevertheless, genetic progress of these breeding 
lines with regard to tolerance via artificial selection can prove to be a timely process.  
 Genetic modification of animals through laboratory manipulation has been utilized for 
over 20 years via gene targeting with the predominant method being the use of zinc finger 
nucleases (ZFNs) and transcriptor activator like endonucleases (TALENS) (Capecchi, 1989). 
Unfortunately, these processes are time consuming have mediocre gene targeting efficiency. It 
was not until recently that a new and more efficient genetic editing system termed clustered 
regularly interspersed short palindromic repeats (CRISPR) paired with CRISPR associated 
protein 9 (Cas9) became available for genetic use, and has proved beneficial through quick and 
accurate genome editing (Jinek et al., 2012).  
Pigs are one of the many animal species that have undergone specific genetic 
manipulation through the CRISPR/Cas9 system, including the alteration of the PRRSV receptor, 
CD163. Genetic alteration of CD163 in macrophages of pigs has been proven successful, 
however many genotypes were produced (Whitworth et al., 2013). A previous study 
demonstrated that one of the many genotypes of genetically edited pigs exhibited resistance to 
infection of a single PRRSV isolate (Whitworth et al., 2015), however evaluation of disease 
resistance to the other produced genotypes as well as other isolates of PRRSV remained 
unknown.  
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The Arteriviridae Family 
Arteriviridae is a family of enveloped positive-stranded RNA viruses which include 
Arterivirus, the only genus in the family. Arteriviridae, in addition to Coronaviridae, 
Toroviridae, and Roniviridae, comprise the order, Nidovirales. These virus families have 
characteristics that are distinct to each, such as Coronaviridae, Toroviridae, and Roniviridae 
comprising some of the largest known RNA viral genomes (23 to 26kb), while Arterividae RNA 
genomes are smaller (13-16kb). However, due to the organization and expression of their 
genomes, there was ample evidence to group these families under the same order. That evidence 
includes a nested subgenomic mRNA for expression of the 3’ proximal ORFS, which encodes 
for the most conserved structural proteins and was the basis for the order (den Boon et al., 1995; 
Gorbalenya et al., 2006).  
The Arterivirus Genus 
Arteriviruses have a tropism for monocytes and macrophages of mammalian lineage and 
can cause persistent or subclinical infections in addition to respiratory disease in an acute phase 
(Snijder et al., 2013). Three other viruses that compose the Arterivirus genus in addition to 
PRRSV are equine arteritis virus (EAV), lactate dehydrogenase elevating virus (LDV), and 
simian hemorrhagic fever virus (SHFV) (Plagemann et al., 1992). Natural hosts of arteriviruses 
range from pigs (PRRSV), horses and donkeys (EAV), mice (LDV), and numerous genera of 
Asian and African monkeys (SHFV). PRRSV is categorized into two distinct genotypes, 
genotype 1 (termed European strain) and genotype 2 (termed North American strain), consisting 
of approximately 60% nucleotide identity thus allocating a wide variation of genetic diversity 
(Forsberg et al., 2002, Chen et al., 2011).
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PRRS Virus 
 Economic Impact  
The United States has been plagued with PRRSV in hog barns for well over 30 years. 
The reproductive losses associated with PRRSV infection are substantial. In 2013, it was 
recorded that breeding herds had reduced reproductive efficiency by 1.44 pigs weaned per sow 
per year. The total annual cost of productivity losses measured up to $302.06 million, equivalent 
to the loss of $52.19 per breeding female or $2.36 per weaned pig for the entire U.S. inventory. 
In 2005, the total annual losses were around $493.57 million in the growing pig population, and 
a loss of $66.75 million in breeding herd However just four years ago, PRRSV cost the industry 
$4.67 for every pig that was marketed leading to an annual cost of $663.91 million or $1.8 
million per day. (Holtkamp et al., 2013; Neumann et al., 2005)..  
 Viral Organization 
The PRRSV genome is comprised of positive-stranded polyadenylated RNA of about 15 
kilobases in size which varies based on the isolate of the virus (Conzelmann et al., 1992). The 
genomic RNA contains a 3’polyadenylated tail which follows the 5’ cap. The untranslated region 
(UTR) of the 5’ end has demonstrated a critical role in subgenomic RNA synthesis as a 
component in translational mechanisms (van den Born et al., 2005). The 3’ poly A tail has been 
considered important for initiation of RNA-dependent RNA polymerase and replication (Godeny 
et al., 1993). Due to its positive stranded properties, PRRSV does not require RNA polymerase 
in its virion and is capable of being directly translated by the host during protein synthesis., thus 
not requiring RNA polymerase in the virion (Meulenberg et al., 1993). Ten open reading frames 
(ORFs) have been identified: ORFs 1a, 1b, 2a, 2b, 3, 4, 5a, 5b, 6, and 7 (Figure 1.1) (Firth et al., 
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2011; Johnson et al., 2011). Multiple ORFs perform a variety of functions and encompass the 
PRRSV virion (Figure 1.2) 
 ORF 1a and ORF 1b encode for the RNA-dependent RNA polymerase and genes coding 
for two large polyproteins (pp1a and pp1ab) that cleave into 14 nonstructural protein (Nsp) 
coding regions by a cascade for four virally encoded proteins (Fang and Snijder, 2010; Ziebuhr 
et al., 2010). The Nsps inhabit 75% of the genome and are required for virus replication. 
Nomenclature for these Nsp’s range from Nsp 1 to Nsp 12.  pp1a is thought to produce Nsp1α, 
Nsp 1β, and Nsp 2 to Nsp 8. Nsp1 and Nsp 7 are further broken down into Nsp 1α and Nsp 1β, 
and Nsp 7α and Nsp 7β, respectively. Papain-like proteases (PLPs) encoded by Nsp1α and Nsp 
1β, Nsp 2, and a chromotrypsin-like serine protease encoded by Nsp 4, perform the entire 
polyprotein processing (den Boon et al., 1995; Han et al., 2009; Tian et al., 2009). Nsp 9 through 
12, products of pp1ab, are associated with virus replication and transcription and are translated 
when the virus enters the cell. They are then processed by proteinases into at least 12 mature 
Nsps and intermediate precursors. These precursors and mature Nsps are potentially accountable 
for RNA synthesis via virus-induced double membrane vesicles (den Boon et al., 1995; Snijder 
and Meulenberg, 1998; van Dinten et al., 1997). 
 ORFs 2 through 7 encode for viral structural proteins (Allende et al., 1999). ORF 2a 
encodes GP2a, a minor glycosylated envelope viral protein that is essential for virus infectivity 
and attachment (Wissink et al., 2004). Minor non-glycosylated viral envelope protein E is a 
product of ORF 2b. Reverse genetics utilizing EAV infectious clones have shown the potential 
function of protein E is required to produce infectious virions, however the exact function is still 
unknown (Snijder et al., 1999). ORF 3 encodes the minor glycosylated envelope viral protein 
GP3. GP3 is considered to be the most variable PRRSV proteins and is highly antigenic. It is also 
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considered to partake in viral neutralization (Cancel-Tirado et al., 2004; Gonin et al., 1998). GP4 
is the product of ORF 4. GP4 is another minor glycosylated envelope viral protein in addition to 
GP3. ORF 4 has been found to be crucial for virus replication via studies involving transfections 
of PRRSV permissive cells with ORF 4 deleted infectious cDNA clones (Welch et al., 2004). 
The ORF 5 gene encodes GP5 glycoprotein and is one of the most variable regions in the PRRSV 
genome (Andreyev et al., 1997). GP5, being one of the most important structural proteins, is a 
major glycosylated envelope viral protein and contains epitopes involved in protection and virus 
neutralization (Ansari et al.,2006). In vivo, most of the neutralizing antibodies are directed to 
GP5 (Gonin et al., 1999) However, studies have found evidence that glycosylation of GP5 has a 
role in escaping or decreasing the neutralizing antibody response by N-glycan shielding (Johnson 
et al., 2003; Wei et al., 2003). Additionally, GP5 appears to be involved with antibody 
dependent enhancement, allowing increased infection of macrophages via the fc receptor on 
PRRSV antibodies (Cancel-Tirado et al., 2004). Inducing apoptosis of the macrophage is another 
function of GP5. During PRRSV infection, specific apoptotic enzymes are activated resulting in 
death of the cell and promoting the release of more PRRSV (Gagnon et al., 2003; Suarez et al., 
1996). ORF 6 encodes the M membrane envelope protein and is one of the most conserved 
structural proteins.  The M protein likely plays a role in virus assembly and budding 
(Meulenberg et al., 1993). The nucleocapsid, or N, protein is encoded by ORF 7 and is highly 
immunogenic in pigs (Meulenberg et al., 1995) The N protein encapsulates the genome and is 
the sole component of the capsid, comprising of approximately 20% to 40% of total viral 
proteins. The C-terminus of the protein plays an essential role in conformational epitopes 
(Meulenberg et al., 1998). The N protein is the most commonly used protein in diagnosis via 
detection of the virus by N-specific antibodies due to its highly conserved immunogenic 
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properties, and being the target of the early immunological response in infected pigs (Loemba et 
al., 1996; Meulenberg et al., 1998). Part of the N protein localizes itself in the nucleus and 
nucleolus of the cell which may play a role in viral pathogenesis such as cell gene expression 
(Rowland et al., 1999). N protein has also demonstrated protein binding that is independent of 
other binding proteins via the formation of an N protein/ importin complex, which was 
discovered by an in vitro pull-down assay (Rowland and Yoo, 2003).  
 Genotypes  
  PRRSV falls into two distinct genotypes with multiple isolates in each, termed the 
European strain (genotype 1) and North American strain (genotype 2). The study of polyclonal 
antisera indicated a difference was present between the two genotypes (Wensvoort et al., 1992). 
Comparison studies have also been performed by sequencing genomes from isolates of each 
genotype. At the genome level, both isolates constitute 60% nucleotide identity. However, major 
differences have been detected at the protein level. Variations include at level of the 5’ and 3’ 
non-coding regions, and in the non-structural coding regions of Nsp and capsid protein 4 (CP4) 
located in ORFs 1a and 1b. Nsp 2 has appeared to possess only 32% amino acid identity and 
included 120 extra residues, while CP4 shared only 42% amino acid identity between the two 
genotypes (Allende et al., 1999).   
 Transmission 
PRRSV has historically been known to be a highly infectious pathogen, needing less than 
1 X10 1 tissue culture infectious dose (TCID50) to infect pigs via the intramuscular route (Yoon et 
al., 1999). Transmission of PRRSV is primarily through close contact between diseased and 
naïve animals. Nose-to-nose contact with urine and feces are the main routes of transmission 
(Rossow et al., 1994; Wills et al., 1997). The minimum infectious dose (MID) varies with the 
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route of viral exposure. For exposure to PRRSV genotype 2 isolate VR-2332 via oral and 
intranasal routes, the infectious dose 50 (ID50) was 10
5.3 and tissue culture infectious dose 50 
(TCID50) was 10
4, respectively (Hermann et al., 2005). There are also reports of virus being 
isolated from semen six days post inoculation and may persist up to 92 days in infected boars. 
Transmission of the virus via insemination has also been detected. PRRSV can replicate in male 
testicular germ cells, induce death via apoptosis, and alter spermatogenesis (Christopher-
Hennings et al., 1995; Reicks et al., 2006; Sur et al., 1997; Yaeger et al., 1993). However, higher 
infectious doses (2 X 105) are needed for transmission via semen as compared to infection via the 
intranasal route (Nelson et al., 2002). PRRSV can also infect fetuses via replication in the 
endometrium of the female and then crossing the maternal-fetal interface, ultimately infecting 
the fetuses. However, not all fetuses may be directly infected with virus. Due to the 
compartmentalizable nature of the placenta with each fetus receiving individual blood and 
nutrient supply and are at different distances from the uterine body, each fetus of which may 
attempt to induce an antiviral response (Karniychuk and Nauwynck, 2013; Rowland, 2010). 
Additionally, normal pig behavior plays a role in PRRSV transmission. Tail and vulva bites, 
scratches, and abrasions can all result from pigs fighting. Aggressive behaviors, especially in 
sows, have shown to promote PRRSV transmission to other animals in the specific pen the 
infected animal is housed in (Bierk et al., 2001). Differences in infectivity have also been 
observed in various isolates, such as aerosol exposure to a genotype 2 isolate, MN-184. The 
recorded ID50 was less than 2, indicating MN-184 is far more infectious than VR-2332 (Cutler et 
al., 2011).  Fomites have served as vectors of PRRSV transmission including but not limited to: 
boots, tools, coveralls, and contaminated needles (Otake et al., 2002a). Mechanical transmission 
of PRRSV from infected pigs to naïve pigs via the species of mosquito, Aedes vexans has also 
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been reported. However, it has not been verified whether mosquitoes could serve as biological 
vectors for the virus (Otake et al., 2002b). Houseflies, particularly the species Musca domestica 
Linnaeus, can harbor PRRSV in their intestinal tract for up to 12 hours after feeding on infected 
animals (Otake et al., 2003). Aerosol transmission of PRRSV has also been measured in 
controlled conditions as a means of pathogen quantification (Hermann et al., 2009).  
 Clinical Signs 
Clinical signs vary betweein the developmental stages of pigs. The hallmarks for signs of 
infection lie with reproductive and other various systemic signs. Particularly for breeding age 
gilts, sows, and boars, reproductive problems are the most obvious and may last 1-4 months post 
infection. These signs include: reduced conception rates, weak-born piglets that lead to higher 
pre-weaning mortality, mummified fetuses, abortions, stillborns, and premature farrowings. This 
age range can also experience lethargy, anorexia, malaise, respiratory distress, and potential 
vomition. Infected boars have produced semen of poor quality, low sperm motility, and a 
reduced number of spermatozoa with normal acrosomes. Infected suckling piglets are known for 
“thumping”, which is associated with dyspnea, and being febrile. Postweaning pigs may have 
chronic infections leading to, rough hair coats, anorexia, lethargy, cutaneous hyperemia, and an 
85% reduction in average daily gain which leads to uneven size within groups.  Secondary 
opportunistic bacterial infections have also been observed in PRRSV infected pigs which 
include: Streptococcus suis, Mycoplasma hyopneumoniae, Escherichia coli, Haemophilus 
parasuis, and Salmonella Choleraesuis (Dee, 2016; Prieto et al., 1996; Zimmerman et al., 2012).  
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 Pathogenicity 
Interactions between PRRSV and its pig host are comprised of a variety of viral 
pathogenesis mechanisms. Detection of a vigorous anti-PRRSV antibody response can be as 
early as 7 to 9-day post infection (DPI). However, this production of early response antibodies 
has been found to promote the infection rather than work in neutralization, thus increasing 
viremia levels (Lopez et al., 2007; Yoon et al., 1996).  Due to the mediocre cell mediated 
immune response, a persistence of infection results due to suppressed T lymphocyte recognition 
of infected macrophages (Xiao et al., 2004).  Subacute viremia covers approximately 28 days 
with mechanisms of respiratory distress and the releasing of cytokines to induce inflammation. A 
failure within the protective immune effectors allow the acute replication of the virus in the 
animal due to the late response of PRRSV neutralizing antibodies and PRRSV specific gamma 
interferon-producing cells (Meier et al., 2003). Following peak viremia around day 7, the 
presence of virus tends to fade slightly with the periodical reappearance of viremia around day 
28 (Boddicker et al., 2011). Virus replication has a tendency to decrease from 9 DPI in the lungs 
potentially due to the appearance of anti-PRRSV antibodies, lack of susceptibility of penetrated 
monocytes, and the shortage of macrophages available for infection (Labarque et al., 2000). 
PRRSV has been found to persist for up to 150 days post infection with persistent shedding 
during the asymptomatic period. Eventually the virus replication levels decrease to minimal and 
undetectable levels and are cleared from the body, however the mechanism responsible for this is 
not clear (Horter et al., 2002, Rowland et al., 2003b). The genetic stability of both non-coding 
regions (NCRs) in the PRRSV nucleocapsid as well as genes coding for the M protein and 
glycoproteins have been found to possess mutations which may account for the persistence of the 
virus (Allende et al., 2000).   
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 Pathological Lesions 
Due to the nature of PRRSV, there are multiple lesions that occur prior to and upon 
necropsy, indicating that the results of infection are multisystemic. Gross lesions at necropsy 
include lymphadenopathy, encephalitis, myocarditis, vasculitis, pneumonia. Lymph node lesions 
are variable but may consist of germinal center hypertrophy and hyperplasia, lymphocyte 
necrosis, and multifocal cystic spaces. Light microscopic lesions can be found in the lymph 
nodes, blood vessels, lung, and heart. The greatest number of lesions under light microscopy can 
be found in the alveolar cells in the cranial lung lobes, with interstitial pneumonia being the 
primary lesion. Alveoli appear to be the most affected with lysed macrophages, syncytial 
alveolar cells, and karyorrhectic debris (Rossow et al., 1995). However, there are no gross nor 
microscopic pathognomonic lesions. Aborted fetuses and stillborns have little value for 
diagnosis. For pigs in all age groups, systemic hypertrophic lymph nodes and interstitial 
pneumonia can be observed upon necropsy (Lager and Halbur, 1996; Stevenson et al., 1993). 
Additionally, genotype 2 PRRSV has been observed to be more pneumovirulent than genotype 1 
based on respiratory clinical signs and lesions both on the gross and microscopic level (Martinez-
Lobo et al., 2011.) 
 Detection of PRRSV 
Diagnostic methods for PRRSV include real time reverse transcription-polymerase chain 
reaction (RT-PCR), enzyme linked immunosorbent assays (ELISA), microbead assay (MBA), 
indirect fluorescent antibody test (IFA), serum neutralization (SN), direct fluorescent antibody 
test (DFA), immunohistochemistry (IHC), and virus isolation. For PRRSV detection in live 
animals, a serum sample is the preferred retrieval method. Real time RT-PCR has been found to 
produce rapid, highly sensitive results with detection of low levels of PRRSV in serum. Real 
time RT-PCR can also detect the strain of PRRSV that is present. However, ELISAs have been 
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the gold standard for detection due to high sensitivity and specificity. Serum is utilized in an 
ELISA and antibodies can be detected 9-13 DPI. ELISAs are less costly than real time RT-PCR, 
however serum samples must be taken later to get a detectable amount of PRRSV antibodies. 
Also, the strain of PRRSV cannot be detected by ELISA. (Collins et al., 1996; Lurchachaiwong 
et al., 2007; Rovira et al., 2007). More recently, microbead assays were developed as a means of 
measuring lower antibody levels and have the capability for simultaneous detection of antibodies 
for more than one disease that may be present in the sample serum (Lin et al., 2011.) A historical 
diagnostic method of PRRSV is through IFA, which can detect PRRSV antibodies restricted to 
PRRSV infected cells. SN branched from IFA and could detect antibodies earlier with higher 
titers, and can differentiate between PRRSV isolates (Yoon et al., 1994). However, both methods 
are used less today, due to in part more rapid results of real time RT-PCR. IHC is a standard 
tissue diagnostic method for deceased animals which has capabilities in detecting PRRSV 
antigen, particularly in the lung (Yaeger, 2002).  
Prevention and Control 
Prevention of the introduction of PRRSV is the utmost important strategy for farms that 
are free of the virus. Biosecurity is key when attempting to prevent an outbreak. Current 
protocols in use include: personnel entry via the Danish entry system or shower-in systems, 
proper facility upkeep with rodent and insect control, quarantine areas for incoming animals, 
sanitation and drying of equipment and trucks, and the use of filtration systems for barn air 
movement (Dee and Deen, 2006; Zimmerman et al., 2012). Immunizations to defend against 
PRRSV have been in the market for many years, particularly modified live virus vaccines. Field 
virus inoculations have also been practiced inducing PRRSV in a region of farms with goals of 
immunizing all present animals. Unfortunately, vaccination has been unable to prevent a virus 
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outbreak. However, there have been reports of vaccinated animals that were infected with 
PRRSV showing reduced nasal shedding, decreased viremia levels, and less extensive lesions 
(Corzo et al., 2010; Park et al., 2014). Unfortunately, one or more of the above protocols is 
breached and the farm may become PRRSV positive. Many control measures can be utilized. 
Total herd depopulation/repopulation, partial depopulation, and herd closure have been shown to 
successfully eliminate PRRSV from a facility (Torremorell and Christianson, 2002). 
Additionally, unidirectional pig flow has shown promise in controlling disease spread. Ensuring 
diseased animals do not come back in contact with their previous locations is critical for 
management of a PRRSV outbreak (Dee and Philips, 1998).  
The Peripheral Blood Mononuclear Cell (PBMC) and Macrophage 
Peripheral blood mononuclear cells (PBMCs) are immune cells circulating in the blood 
with a round nucleus. Monocytes, and lymphocytes comprise the PBMC category. Isolation of 
PBMCs depends on the density of the PBMCs and the other components in whole blood. 
Successful isolation includes the use of a density gradient medium such as Ficoll™ 
(Riedhammer et al., 2014). Porcine 2A10 antigen expressed on tissue macrophages has been 
found to possess sequence homology with human CD163. However, most blood monocytes are 
negative 2A10. Receptor expression on porcine macrophages can be measured via the 
application of 2A10 mab (Bullido et al., Sanchez et al., 1999). If measuring particular receptor 
expression to evaluate its function, a means of cell stimulation is necessary. The use of colony 
stimulating factors are common to differentiate monocytes into macrophages. Colony stimulating 
factors (CSF) are essential for the survival of blood monocytes during in vitro cell culture. 
Granulocyte-monocyte cell stimulating factor (GM-CSF), is a useful tool for maturing blood 
monocytes to obtain differentiated macrophages that resemble alveolar macrophages (Akagawa, 
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2002; Metcalf, 1986). Under specific culture conditions, GM-CSF can be used to differentiate 
blood derived monocytes into mature macrophages, thus upregulating the expression of 2A10 
and increasing the opportunity to measure CD163 expression with 2A10 mab. 
Macrophages are derivatives of bone marrow cells and are a hallmark component of the 
innate as well as adaptive immune responses due to their phagocytic properties with engulfing 
large particulate matter. Macrophages ingest bacteria, viruses, fungi, immune complexes, and 
cellular debris. Additionally, they aid in the process of restoring homeostasis and are also 
involved in disease (Aderem and Underhill, 1999; Dale et al., 2008). Healing and tissue repair 
has also been discovered as a physiological component of macrophages via the release of 
angiogenic propagators and nitric oxide (NO) (Stallmeyer et al., 1999).  
Macrophages have the capacity to differentiate and mature in response to various stimuli. 
Adapted from T lymphocyte nomenclature, macrophages can be classified as M1 and M2 based 
on the type of activation that was evoked (Mills et al., 2000). M1 macrophages are considered to 
be classically activated, as they perform phagocytosis and promote inflammation. M1 
macrophages are stimulated via gamma interferon combined with lipopolysaccharide (LPS) or 
tumor necrosis factor (TNF). M1 macrophages participate in inflammatory immune responses. 
Alternatively, macrophages may be of the M2 phenotype, and are broken down into three 
subclasses. M2a macrophages are stimulated by IL-4 and IL-13. M2b macrophages are 
stimulated by immune complexes coupled with toll-like receptor. M2c macrophages are 
stimulated by secretion of IL-10. M2 macrophages are involved in immunoregulation, Th2 
activation, and tissue remodeling (Mantovani et al., 2004; Murray et al., 2014; Sang et al., 2015; 
Singleton et al., 2016.)  
 15 
 
The PRRSV receptor: CD163 
 Structure 
Cluster of Differentiation 163 (CD163) is a 130 kDa long protein plays many roles in 
various biological processes in mammals. Expression of CD163 is restricted to cells specifically 
of the macrophage/monocyte lineage (Van den Huevel et al., 1999). CD163 is a member of the 
scavenger receptor cysteine rich (SRCR) superfamily specifically Class B consisting of nine 
SRCR domains, 17 exons, 16 introns, two Proline Serine Threonine (PST) domains, and a 
cytoplasmic tail (Law et al., 1993).  
 Physiological Properties 
CD163 was first identified as a macrophage membrane receptor for the endocytosis of 
haptoglobin-hemoglobin (HpHb) complexes and acts as a scavenger for free haptoglobin as a 
preventative measure of oxidative toxicity (Kristiansen et al., 2001). Particularly, SRCR domain 
3 is the main determinant in coupling and interaction with endocytosis of HpHb complexes 
(Madesn en et al., 2004). Additionally, metabolites are released following HpHb degradation. 
They include bilirubin, CO, and free iron and possess strong anti-inflammatory as well as anti-
oxidative effects (Figure 1.2). The result of the release of these metabolites is a negative 
feedback loop that reduces inflammation (Soares and Bach, 2009). Macrophages are a crucial 
component to clearing infection, but can generate tissue damage if left unchecked. As a response 
to inflammation, CD163 on macrophages produces an anti-inflammatory effect via the secretion 
of IL-10, an anti-inflammatory cytokine, and creates a positive feedback loop. The result is the 
upregulation of IL-10 expression to induce an anti-inflammatory effect to the inciting stimulus, 
thus reducing the macrophage immune response  (Figure 1.2) (Buechler et al., 2000; Philippidis 
et al., 2004). However, pro-inflammatory cytokines such as IL-1β, IL-6, GM-CSF, and TNF-α, 
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are also produced through the cross-linking of CD163 with bacteria or antibodies. An increased 
inflammatory response will promote more macrophage activity, thus creating risk of tissue 
damage (Fabriek et al., 2009, Polfliet et al., 2006,).  
Soluble CD163 
 In addition to membrane-bound CD163, a soluble form of CD163 (sCD163) is present in 
serum and other fluids (Moller et al., 2002). HbHp complexes have been found to also bind to 
sCD163, but at a much lower affinity when compared to membrane CD163 (Møller et al., 2010). 
sCD163 has been found to be a result of shedding as a part of normal physiology and by a 
number of inflammatory mechanisms. These include the induction of toll-like receptor (TLR) 4 
activation from exposure to LPS, thrombin, oxidative stress, and crosslinking of the Fcγ on 
antibodies (Chung et al., 2011; Hintz et al., 2002; Møller et al., 2002; Sulahian et al., 2004; 
Timmermann and Hӧgger, 2005). The actual function of sCD163 is still unknown. However, it 
can serve as a useful biomarker of macrophage activation in response to inflammation with a 
variety of diseases (Møller et al., 2012).  
 Virus-Receptor Interaction 
Porcine CD163 plays a role as a key mediator for infection of PRRSV (Calvert et al., 
2007). Of the 17 exons, exon 7 codes for SRCR domain 5, and serves as the critical facilitator for 
PRRSV infection and is therefore a potential target for genetic manipulation. (Van Gorp et al., 
2010). The PRRSV major envelope protein, GP5, was thought to bind to the alveolar 
macrophage receptor sialoadhesin (Sn/SIGLEC/CD169) prior to internalization of PRRSV (Van 
Breedham et al.2010). Pigs that were genetically edited to completely lack the once intact 
sialoadhesin receptor on alveolar macrophages revealed it is not required for PRRSV infection 
(Prather et al., 2013).  However, a heterotrimer (consisting of GP2, GP3and GP4 of the PRRSV 
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virion) interacts with SRCR domain 5 of CD163 on the extracellular membrane of macrophages 
resulting in propagation of virus uncoating and replication leading to eventual infection (Das et 
al., 2010, Van Gorp et al., 2010).   
 
The CRISPR/Cas9 System 
The CRISPR/Cas9 system has recently become an efficient genetic editing tool and was 
awarded the 2015 science breakthrough technology of the year due to incredibly precise and 
efficient genome editing. First discovered in 1987, CRISPRs were identified in Escherichia coli 
with a sequence element series consisting of 29-nucleotide repeats separated by 32-nucleotide 
‘spacer’ sequences (Ishino et al., 1987). However, this discovery was of interest in genetics in 
the 2000s when they were identified in many prokaryotes with multiple CRISPR-associated 
(Cas) proteins (Jansen et al., 2002, Mojica et al., 2000).  
 
CRISPR/Cas9: A Genetic Engineering Breakthrough 
Prior to CRISPR/Cas9 usage in genetic manipulation strategies, the primary route of 
genetic modification was through gene targeting with homologous recombination (Capecchi, 
1989). However, this method is rather inefficient and was eventually replaced with customized 
zinc finger nucleases (ZFNs) and meganucleases which work by cleaving specific DNA target 
sequences in vivo and creating double stranded breaks at pre-selected sites. The breaks are then 
repaired via homologous recombination or non-homologous end joining (NHEJ) (Bibikova et al., 
2003; Cathomen and Joung, 2008). ZFNs had the spotlight of genetic engineering for many years 
until transcription activator-like effector nucleases (TALENs) showed signs of significant 
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improvements of traditional genetic modifications with increased applicability of targeting the 
desired edited sequence through larger amino acid modules compared to ZFNs (Boch et al., 
2009; Christian et al., 2010).  
Until a few years ago, the use of ZFNs or TALENS were considered the only method of 
genetic alteration. The CRISPR/Cas9 system has been found to be an efficient alternative for 
inducing targeted genetic editing. The editing mechanism is achieved through short segments of 
foreign DNA, also known as “spacers”, which are incorporated with the CRISPR genomic loci 
and are then transcribed and processed into short CRISPR RNAs (crRNAs). Pathogenic DNA is 
then silenced by Cas proteins due to the crRNAs annealing to trans-activating crRNAs 
(tracrRNAs) producing sequence-specific cleavage (Figure 1.3). It has been found that the Cas9 
protein requires a baseline sequence within the crRNA and a conserved dinucleotide-containing 
protospacer adjacent motif (PAM) sequence upstream of the crRNA binding region in order to 
perform target recognition and double stranded breaks (Jinek et al., 2012). By re-designing the 
crRNA, the CRISPR/Cas9 system can be re-targeted to cleave practically any DNA sequence.  
Designing of Genetically Edited Animals 
Prior to genome editing of eukaryotes, prokaryotes were the first subjects of use for 
application of CRISPR technology for bacterial strain typing, particularly for Mycobacterium 
tuberculosis (Groenen et al., 1993). In 2002, many CRISPR associated (Cas) proteins were 
found to be invariably adjacent to a CRISPR locus indicating a functional relationship as stated 
previously (Jansesn et al., 2002). It was not until 2005 that CRISPRs were described to protect 
prokaryotes from invading foreign DNA, potentially from plasmids or viruses through a 
mechanism that is analogous to eukaryotic RNA interference mechanisms (Makarova et 
al.2006). The type II CRISPR/Cas9 adaptive immune system has been shown to facilitate RNA-
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guided site-specific cleavage of DNA, which is now the tool in current use for CRISPR/Cas 9 
system genetic targeting (Deveau et al., 2010; Horvath and Barrangou, 2010; Makarova et al., 
2011; Bhaya et al., 2011). A successful attempt at reconstituting a CRISPR system derived from 
Streptococcus pyogenes in a mammalian cell line, facilitating efficient genome editing occurred 
in 2013 with a later study confirming high efficiency RNA-genome targeting in several human 
and mice cell lines (Cong et al., 2013; Mali et al., 2013). CRISPR/Cas9 technology has 
exponentially skyrocketed in the genome editing realm and many animal species have now been 
subject to such manipulation ranging in species from: mice (Cong et al., 2013), pigs (Whitworth 
et al., 2013) cattle (Tan et al., 2013), mosquitoes (Gantz et al., 2015), and even dogs (Arnott et 
al., 2015).  
Genetically Edited Pigs Are Protected from PRRSV 
In Whitworth, et al. 2013, the CRISPR/Cas9 system was utilized to produce genetically 
edited pigs from in vitro derived oocytes and embryos (Figure 1.5). After manipulation of 
somatic cells through homologous recombination (HR) or non-homologous end joining (NHEJ) 
by CRISPR/Cas9, the cells were used to produce genetically edited pigs through somatic cell 
nuclear transfer (SCNT). The edited embryos or oocytes were then surgically implanted into 
surrogate gilts via embryo transfer (ET) and an array of genotypes were produced. Challenge 
studies performed by Whitworth et al. 2015 revealed that pigs lacking the CD163 receptor, due 
to manipulation by the CRISPR/Cas9 system, were resistant to a single strain of PRRSV, a 
genotype 2 isolate NVSL 97-7895.  
Proceeding with an additional in vivo study, more gene edited pigs were challenged 
against a genotype 1 strain of PRRSV, SD 13-15, and again with the genotype 2 strain, NVSL 
97-7895. In addition to the Null pigs being challenged, hCD163L-1 pigs which have a swapped 
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domain of SRCR domain 5 with a human-like CD163 SRCR domain 8, were challenged as well. 
Blood was collected intravenously on days 0, 4, 7, 11, and 14 post infection. On day 15, pigs 
were euthanized and lung lavages were performed to collect PAMS.  
Lung tissue was also collected at necropsy and aliquoted in 10% formalin, embedded in 
paraffin, and processed for histopathology. A board-certified pathologist performed 
histopathology. Scores ranged 0-4 with 0 for no microscopic lesions to 4 for severe interstitial 
pneumonia that includes ~75 to 100% of lung tissue. WT and hCD163L-1 lung scores ranged 
from 1 to 4 ranging from mild to severe interstitial pneumonia while the Null pigs presented 
scores of 0 with normal lung architecture. (Figure 1.6) 
Viremia levels in serum determined by RT-PCR are shown in figures 1.7 A and B as 
averages per genotype in units of Log10 templates per reaction. The minimum threshold of 
determining infected sera was set at 500 relative fluorescence units (RFU). Figure 1.7 A 
represents viremia levels of genotypes of pigs challenged with PRRSV genotype 1 isolate SD 13-
15. The WT group showed a typical PRRSV viremia curve with peak viremia approximately 7-
11 DPI. The Null and hCD163L-1 group did not show signs of virus replication. Figure 1.7 B 
shows viremia levels of genotypes of pigs challenged with PRRSV genotype 2 isolate NVSL 97-
7895. WT and hCD163L-1 pig groups revealed values of virus replication with a typical PRRSV 
viremia curve for both groups. The Null group did not show any signs of virus replication or 
viremia (Wells et al., 2017).  
IgG antibody levels were determined via a multiplex assay in figure 1.8, and are 
represented in units of net Median Fluorescent Intensity (MFI) based on parameter from the bead 
sets that were used. For genotype 1 PRRSV, only WT pigs were observed to have a recognizable 
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MFI. For genotype 2 PRRSV infections, WT and hCD163L-1 pigs both had an observable MFI. 
MFI levels of Null pigs were unobservable for both PRRSV genotypes. (Wells et al., 2017).  
CD163 performs a physiological function by scavenging HpHb complexes, as a means of 
prevention of oxidative toxicity (Kristiansen et al., 2001). Questions were raised regarding the 
Hp levels of CD163 gene edited pigs, and the animal’s homeostatic status. A double antibody 
sandwich ELISA was performed to measure Hp levels in the serum of PRRSV negative WT, 
hCD163L-1, and Null pigs. Elevated Hp levels were found in the gene edited pigs, while WT 
were shown to have less circulating levels of Hp (Figure 1.9) (Wells et al., 2017). This may be in 
part due to the receptor being rendered nonfunctional in Null pigs and less expressive in the 
hCD163L-1 pigs. However, when observed on the hoof, both edited genotypes of pigs appeared 
to be bright, alert, and responsive, just like their WT cohorts.    
In Wells et al., 2017, it was concluded that pigs with a replacement of porcine CD163 
SRCR domain 5 with a CD163-like homolog, also termed hCD163L-1 pigs, were resistant to 
genotype 1 PRRSV but not genotype 2 PRRSV. Additionally, we found the Null pigs to also be 
resistant to the genotype 1 PRRSV. These results led to the use of in vitro challenge studies to 
evaluate PRRSV resistance in a larger quantity.  
Purpose 
The purpose of this study was to evaluate the potential resistance that macrophages from 
gene edited pigs may have to multiple isolates of genotype 1 and 2 PRRSV. However, alternative 
methods for macrophage collection besides animal sacrifice has also warranted investigation. 
The low replication fidelity of PRRSV leaves it to be an international virus that has yet to be 
prevented. Control efforts have been in place for a number of years leading to some success for 
eventual eradication of PRRSV from individual hog sites, but eradication on a larger scale has 
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not been achieved. Unfortunately, a preventative cure has yet to established. The verification of 
gene edited pigs posing resistance to a breadth of PRRSV isolates may hold the key to 
propagating these animals into the worldwide hog commodity market. 
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Tables and Figures 
 
Figure 1.1: Representation of the PRRSV genome 
The PRRSV genome consists of 10 open reading frames 10 (ORFs). ORFs 1a and 1b produce 
polyproteins to generate nonstructural proteins. ORFs 2a and 2b as well as 3 through 7 produce 
viral structural glycoproteins. 
 
 
Courtesy of Benjamin Trible 
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 Figure 1.2: Schematic representation of the PRRSV virion 
The PRRSV virion is consists of an envelope, N protein, M protein, as well as major 
glycoprotein 5 and minor glycoproteins 2a, 3, and 4. Das et al.2010 and Van Gorp et al.2010 has 
shown that GP2a, and GP4 interact with domain 5 of CD163 for attachment and internalization. 
 
 
 
  
  
 Courtesy of Benjamin Trible 
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Figure 1.3: Diagram of macrophage receptor porcine CD163 
 
(A) Diagram showing CD163 protein SRCR (ovals) and PST (squares) domains and 
corresponding gene exons. (B) Peptide sequence comparison of porcine CD163 SRCR 5 with the 
HCD163L1 SRCR 8 homolog.   The figure is based on GenBank accession numbers AJ311711 
(pig CD163) and GQ397482 (hCD163L-1).  
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Figure 1.4: Regulation of inflammation via CD163 SRCR 3 breaking down Hp-Hb 
complexes 
 
After breaking down Hp-Hb complexes, the macrophage incorporates the products in the 
lysosome where they are metabolized and excreted as metabolites of either free iron, carbon 
monoxide, or bilirubin which in turn reduces inflammation. 
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Figure 1.5:Various genetic constructs of pigs by CRISPR/Cas9 system.  
From Wells et al. 2017. Various genetic constructs of WT, and CD163 edited pigs.  
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Figure 1.6: Lung scores of PRRSV infected pigs 
 Post mortem lung scores are below. WT and hCD163L-1 lung scores ranged from 1 to 4 
ranging from mild to severe interstitial pneumonia while the Null pigs presented scores of less 
than 1 with normal lung architecture. hCD163L-1 pigs infected with a type 2 isolate were 
observed to have a higher lung score than those infected with a type 1 isolate.  
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Figure 1.7: Average viremia levels in serum of PRRSV infected pigs by real time RT-PCR 
at log10 templates/ reaction.  
Genotypes challenged include CD163 hCD163L-1, Null, and WT. A) Viremia levels of Type 1 
(SD 13-15) infected pigs. Only WT pigs showed noticeable levels of viremia. B) Viremia levels 
of Type 2 (NVSL) infected pigs. Only pigs of the Null genotype showed no detectable levels of 
viremia.  
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Figure 1.8: Median fluorescence intensity level of CD163 antibody produced in serum of 
PRRSV infected pigs.  
Genotypes challenged include hCD163L-1, Null and wildtype (non-edited) pigs. The Y-axis 
indicates median fluorescence intensity of the parameter of microbeads in regard to hCD163L-1 
to antibody levels, specifically IgG. The X-axis indicates DPI. A) Antibody levels of Type 1 (SD 
13-15) infected pigs. B) Viremia levels of Type 2 (NVSL) infected pigs. 
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Figure 1.9: Haptoglobin levels in serum of WT, hCD163L-1, and Null pigs  
 Circulating haptoglobin levels for HL11m (hCD163L-1), and Null pigs were higher than WT 
pigs, potentially due to lower or no expression levels of CD163, a scavenger receptor that 
recycles haptoglobin  
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Chapter 2 - Materials and Methods 
PAMs Collection 
PAMs were collected 15 DPI at necropsy. Three collection tubes each containing 50 mL 
of phosphate buffered saline (PBS) were used to perform lung lavages to collect the PAMs and 
then temporarily stored on ice until further aliquoted. Lung tissue from each pig was also 
collected and stored in 200 mL sample cups with 150 mL formalin for histopathology. Lungs 
were removed from euthanized pigs and lavaged by pouring 100 ml of cold PBS into the trachea. 
The trachea was clamped with hemostats and the lungs gently massaged for a minimum of 30 
seconds. The alveolar contents were poured into 50 ml centrifuge tubes and stored on 
ice. Macrophages and other cells were removed by centrifugation at 1200 x g for 10 minutes at 
4°C. The resulting pellet was resuspended in cold sterile PBS and was washed once. The cell 
pellet was resuspended in freezing media comprised of 50% RPMI 1640, 50% FBS, and 10% 
DMSO (Thermofisher Scientific, Lenexa, KS, USA), and 45% FBS (Sigma Aldrich, St. Louis, 
MO, USA) then stored in liquid nitrogen until use.  
PBMC Isolation 
Peripheral blood mononuclear cell (PBMC) isolation was performed using 50 ml 
SepMate50 PBMC isolation tubes (Stem Cell Technologies, Vancouver, British Columbia, 
Canada). 3.5 ml Ficoll-Paque Premium™ density gradient medium (GE Healthcare Life 
Sciences, Pittsburgh, PA, USA) was added to empty 50 ml SepMate50 tubes. 15 ml blood 
samples were diluted with 15 ml PBS with 2% FBS. Diluted blood samples were pipetted down 
the sides of the of the SepMate50 tubes. SeptMate50 tubes with blood samples were centrifuged 
at 1200 x g for 20 minutes at room temperature. The top layer of mononuclear cells (MNCs) was 
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poured off into a new 50 ml conical tube and was washed with PBS with 2% FBS. MNCs were 
centrifuged at 300 x g for 8 minutes at room temperature and repeated once. MNCs were then 
resuspended in freezing media with 45% FBS, 45% DMEM, and 10% DMSO and stored at -
80°C in 1ml aliquots in 1.5 ml Nalgene System 100 Cryogenic Tubes (Thermofisher Scientific, 
Lenexa, KS, USA). 
Isolates 
PRRSV isolates (Figure 2.2) grown from Marc-145 cell lines were titrated from 101 to  
106  infectious units/ml. 100 µl of PRRSV isolate was added to 900 µl of RPMI culture media 
creating a 1:10 dilution. 100 µl of diluted PRRSV isolates were then added in triplicate to the to 
appropriate wells of naïve PAMs. Plates were incubated overnight at 37°C with 5% CO2. 
Isolates were chosen based on their genotype, different nucleotide and peptide sequences, date of 
initial isolation, and level of virulence ranging from low virulence to atypical (highly virulent).  
Flow Cytometry of PAMs 
For antibody staining, approximately 1X106 PAMs were placed into 12 mm x 75 mm 
polystyrene flow cytometry (FACS) tubes and incubated for 15 minutes at room temperature in 
1ml of PBS with 10% normal mouse serum.  Cells were pelleted by centrifugation and re-
suspended in 100 µl PBS and 1% BSA along with 5 µl of FITC-conjugated mouse anti-porcine 
CD169 mAb and 5ul of PE-conjugated mouse anti-porcine CD163 mAb (Abd Serotec/Bio-Rad 
companies, Hercules, CA, USA) (Table 2.1). After a 30-minute incubation, the cells were 
washed twice with PBS containing 1% BSA (Fraction V; Hyclone) and immediately analyzed on 
a BD LSR Fortessa flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA) with FCS 
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Express 5 software (De Novo Software, Los Angeles, CA, USA).  A minimum of 80,000 
macrophages were analyzed for each sample.  
PAMs In Vitro Infection (End-Point Dilution) 
Frozen cells were thawed on ice, counted using a Scepter™ 2.0 handheld automated cell 
counter (EMD Millipore, Temecula, CA, USA) and adjusted to a concentration of 5x105 cells/ml 
of media (RPMI 1640 with 10% FBS, PenStrep, and Fungizone: RPMI-FBS) (Gibco, 
Thermofisher Scientific, Lenexa, KS, USA). PAMs (100 ul/well) were plated onto 96 well plates 
and incubated overnight at 37°C in 5% CO2. The cells were gently washed and infected by adding 
serial 1:10 dilutions of PRRSV, in triplicate to rows in the 96 well plate. After an overnight 
incubation at 37°C in 5% CO2, cells were washed and then fixed for 10 min with 80% acetone. 
After drying, 50uL per well of the PRRSV specific SDOW-17 mAb (Rural Technologies Inc., 
Brookings, SD, USA), diluted 1:1000 in 1% fish gelatin (Sigma Aldrich, St. Louis, MO, USA) 
was added to each well. After a 30-minute incubation at 37°C, the antibody was removed and cells 
washed with PBS. Cells were stained with Alexafluor 488 mAb (Thermofisher Scientific, Lenexa, 
KS, USA) and diluted 1:200 in 1% fish gelatin. Cells were incubated for 30 minutes away from 
light at 37°C, then washed with sterile PBS, and viewed under a fluorescence microscope.  
PAMs In Vitro Infection (Percent Infection) 
Frozen cells were thawed on ice, counted using a Scepter™ 2.0 handheld automated cell 
counter (EMD Millipore, Temecula, CA, USA) and adjusted to a concentration of 5x105 cells/ml 
of media (RPMI 1640 with 10% FBS, PenStrep, and Fungizone: RPMI-FBS) (Gibco, 
Thermofisher Scientific, Lenexa, KS, USA). PAMs (500 ul/well) were plated onto 48 well plates 
and incubated overnight at 37°C 5% CO2. The cells were washed and infected with 1:100 diluted 
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PRRSV of both Type 1 and Type 2 genotypes in singlicate to rows in the 48 well plate. After 
incubation, overnight at 37°C in 5% CO2, cells were washed then fixed for 10 min with 70% 
acetone. After drying, 250uL per well of the PRRSV specific SDOW-17 mAb (Rural Technologies 
Inc., Brookings, SD, USA), diluted 1:1000 in 1% fish gelatin (Sigma Aldrich, St. Louis, MO, 
USA) was added to each well. After a 30 minute incubation at 37°C, the antibody was removed 
and cells washed with PBS. Cells were then stained with 250µl/well Alexafluor 488 mAb 
(Thermofisher Scientific, Lenexa, KS, USA) diluted 1:200 in 1% fish gelatin. Cells were incubated 
for 30 minutes away from light at 37°C, then washed with sterile PBS. Cells were viewed under a 
fluorescence microscope and percent infections were recorded in counts of three windows/well 
counting 60-80 cells per window.  
 
Cultured Macrophages Derived from PBMCs In Vitro Infection 
Aliquoted PBMCs of uninfected WT, hCD163L-1 and Null pigs in freezing media with 
50% FBS, 50% DMEM, and 10% DMSO were thawed from liquid nitrogen, washed and 
resuspended in 5ml of culture media RPMI 1640 with penstrep, 7%FBS, fungizone, and 
gentimicin and plated on a Costar® 6 Well Clear TC-Treated cell culture plate (Corning Inc., 
Corning, NY, USA) with a minimum cell concentration of 3X106 cells/well. 24 hours later 
culture media was replaced with fresh media containing 20ng/ml of 1:100 diluted 
granulocyte/monocyte colony stimulating factor (GM-CSF) (Life Technologies, Carlsbad, CA, 
USA). Blood monocytes were cultured for approximately for three days with fresh media with 
GM-CSF being added on day one after initial plating. On the fourth day, fresh media was added 
along with 250 µl per well Type 2 isolate VR-2332 in a 1:20 dilution and incubated for 24 hours. 
After incubation, cells were washed with sterile PBS and fixed with 70% acetone for 15 minutes 
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and then washed with PBS Tween and PBS prior to application of 1ml per well of 1:2000 diluted 
PRRSV tagged mAb SDOW and 1:200 diluted fAb Alexafluor 594. Following fixation and 
staining, plates were evaluated on a fluorescence microscope to determine percent infection.  
Freezing of Cultured Macrophages from PBMCs 
PBMCs were isolated via the protocol above and then cultured in media (RPMI 1640 
with 10% FBS, PenStrep, and Fungizone: RPMI-FBS) (Gibco, Thermofisher Scientific, Lenexa, 
KS, USA) for six days at 37°C, being stimulated with GM-CSF (Life Technologies, Carlsbad, 
CA, USA) every three days. On the sixth day, cells were washed with PBS and treated with 5 
mls of Versene solution (Gibco, Thermofisher Scientific, Lenexa, KS, USA) and incubated at 
37°C for 20 minutes. Cells were then removed with cell scrapers that consisted of a 25cm handle 
and 1.8cm blade (BD Biosciences, Franklin Lakes, NJ, USA), and then aliquoted into 15 ml 
conical tubes. The samples were then centrifuged at 800Xg for 10 minutes. The supernatant was 
decanted and the cells were resuspended in freezing media (50% C80 EZ (Cryocrate, Columbia 
MO, USA)), 50% DMEM, 10% DMSO), and aliquoted into 1 ml Nunc™ Cryotube™ vials 
(Thermofisher Scientific, Lenexa, KS, USA). Samples were frozen at -80°C in a Nalgene™ Cryo 
1°C Freezing container (Thermofisher Scientific, Lenexa, KS, USA) for 24 hours. After the 
freezing period, samples were thawed and suspended in culture media and centrifuged at 800Xg 
for 10 minutes. Samples were then resuspended in culture media and plated on a Costar® 24 
Well Clear TC-Treated cell culture plate (Corning Inc., Corning, NY, USA) at 1ml per well. 24 
hours later, cells were washed with sterile PBS and fixed with 70% acetone for 15 minutes and 
then washed with PBS Tween and PBS prior to application of 1ml per well of 1:500 diluted 
Invitrogen™ CD163/M130 mab (Thermofisher Scientific, Lenexa, KS, USA) and 1:200 diluted 
 37 
 
fAb Alexafluor 594. Following fixation and staining, plates were evaluated on a fluorescent 
microscope to determine percent fluorescence.
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Tables and Figures 
 
Table 2.1: Conjugated antibody types for flow cytometry 
 
Antibody Isotype Concentration Flurochrome 
CD163 Mouse Anti-pig IgG1 .1mg/ml PE 
CD169 Mouse Anti-pig IgG1 .1mg/ml FITC 
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Table 2.2:Viruses used for In Vitro PAM Infections 
 
 
Virus Type Year 
Isolated 
GenBank 
Acc# 
NVSL 97-7895 2 1997 AY545985 
KS06-72109 2 2006 KM252867 
P129 2 1995 AF494042 
VR2332 2 1992 AY150564 
CO90 2 2010 KM035799 
AZ25 2 2010 KM035800 
MLV-ResPRRS 2 NA* AF066183 
KS62-06274 2 2006 KM035798 
KS483 (SD23983) 2 1992 JX258843 
CO84 2 2010 KM035802 
SD13-15 1 2013 NA 
Lelystad 1 1991 M96262 
03-1059 1 2003 NA 
03-1060 1 2003 NA 
SD01-08 1 2001 DQ489311 
4353PZ 1 2003 NA 
*NA, Not available 
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Chapter 3 - Results 
CD163 Surface expression levels on PAMs 
Surface expression levels of CD163 and CD169 were evaluated using flow cytometry. 
PAMs were prepared with PE and FITC conjugated antibodies for CD163 and CD169 
respectively and ran through the flow machine. The machine was programmed to detect 
macrophages and monocytes in each sample that exhibit CD163 and CD169 surface expression. 
Dot plots were created in cooperation with the running samples to detect forward scatter (FSC) 
for cell granularity and side scatter (SSC) for cell size. A population of macrophages and 
monocytes was selected from the FSC/SSC dot plot and evaluated on another dot plot for CD163 
expression on the y-axis and CD169 expression on the x-axis. Quadrants were divided up as Q1 
(CD163 +/CD169 -), Q2 (CD163 +/CD169 +), Q3 (CD163 -/ CD169 -), and Q4 (CD163 -
/CD169 +).  WT macrophages showed an average of 80% of selected cells expressing both 
CD163 and CD169 in Q2. hCD163L-1 macrophages showed an average of 40% in Q2 and 50% 
in Q4. Null pigs showed an average of over 90% of selected cells negative for CD163 yet still 
expressing CD169 in Q4.  PAMs from the CD163 Null pigs did not show evidence of CD163 
surface expression, but expression levels of CD169 were normal.  For the hCD163L-1 pigs, both 
CD163+ and CD169+ were detected on PAMs (Figure 3.1). However, expression of CD163 was 
reduced compared to the WT PAMs.  Surface expression levels for CD163 on the CD169-
positive cells ranged from no detectable CD163 expression to cells possessing moderate levels of 
CD163 expression.  The results for the hCD163L-1 pigs suggest there is presence and location of 
a PGK-Neo marker which may have influenced the reduced expression of CD163. 
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In Vitro PRRSV Infection of PAMs (End-Point Dilution) 
Infection rates for PAMs were assessed with the 50% tissue culture infectious dose 
(TCID50)/ml and was calculated using the Reed-Muench method (Reed and Muench, 1938). Figure 
3.2 compares all three genotypes challenged against both type 1 and type 2 PRRSV isolates. 
hCD163L-1 PAMs measure one half fold less TCID50 values than WT PAMs. Null PAMs failed 
to support any PRRSV infection. Figure 3.3 also shows hCD163L-1 (HL11) PAMs measuring one 
half fold less TCID50 values compared to WT PAMs when infected with only type 2 isolates.  
In Vitro PRRSV Infection of PAMs (Percent Infection) 
Infection rates for PAMs were assessed by calculating percent infection in three windows 
per well consisting of 60-80 cells per window at 40X magnification. In concurrence with TCID50 
measurements in the previous result, Figure 3.3 A reveals hCD163L-1 is one half fold less in 
percent infection compared to WT PAMs when infected with Type 2 isolates. Figure 3.3 B 
shows hCD163L-1 domain 8 mimic PAMs are resistant to Type 1 isolates.  
In Vitro PRRSV Infection of Cultured Macrophages Derived from PBMCs 
After three days of culture and stimulation by GM-CSF, mature macrophages were 
derived from PBMCs that were isolated from whole blood. Percent infections were counted in 3 
windows/ well consisting of 40-60 cells per window. Due to decreased concentration of cultured 
PBMCs compared to PAMs there were less available cells to count in each window. Following 
the PBMC infections, in Figure 3.4 approximately 91% of WT macrophages were infected, 39% 
of hCD163L-1 macrophages were infected, and Null cells did not sustain any infection. No 
infection of Null cells is a likely result of the cultured macrophages lacking the expression of 
CD163 and the hCD163L1 domain 8 mimic (HL11m) cultured macrophages having an altered 
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CD163 receptor due to a domain swap and and potentially from the insertion of a PGK neomycin 
cassette.  Figures 3.5 A, B, and C, represent images of PBMC derived macrophages under 
microscopic fluorescence. These images support figure 3.4 regarding pig genotype and PRRSV 
infectivity.  
In Vitro Fluorescence of Frozen Macrophages Derived from PBMCs 
Macrophages were cultured from PBMCs in whole blood and were frozen at -80° for 24 
hours. Cells were then thawed, fixed with 70% acetone, and stained with CD163/M130 mab 
instead of being infected with PRRSV. Cells were then stained with a fluorescent antibody for 
CD163 positive cell detection. Figure 3.6 A exhibits the percentage of cells that expressed 
fluorescence in accordance with individual pig genotype. Figure 3.6 B shows the average percent 
fluorescence of cultured macrophages. Macrophages of the hCD163L-1 genotype exhibit 
approximately a half fold less fluorescence than WT macrophages, indicating an altered CD163 
receptor. Null macrophages did not express any fluorescence.  
Successful culture and infection of MNCs has exhibited results similar to in vitro 
infections of PAMs derived from sacrificed animals. Fixation and staining of the macrophages 
with a mab and fab led to the result of fluorescent cells under a fluorescent microscope, 
indicating CD163 was present on WT cells. Macrophages of the gene edited pigs showed little or 
no fluorescence, which portrayed similar results to in vitro PRRSV infection of cultured 
macrophages that were not stored, and in vitro infection of PAMs. However, further studies need 
to be conducted to account for the loss of cell numbers potentially due to freezing and thawing.  
 43 
 
Tables and Figures 
Figure 3.1:Receptor Expression Levels of CD163 and CD169 on PAMs 
Receptor expression levels were observed via flow cytometry with FITC, (fluorescein 
isothiocyanate) and PE (PE-Cy7). A) The majority of WT PAMS fell into quadrant 2, indicating 
that both CD163 and CD169 was being expressed. The majority of hCD163L-1 PAMS fell into 
quadrants 2 and 4, indicating that both CD163 and CD169 was being expressed, but not at very 
high levels. The majority of Null PAMS fell into quadrant 4, indicating that CD163 is not 
expressed, but CD169 was being expressed. B and C) Levels of fluorescence for CD163 or 
CD169 on a linear scale. The black line indicates background fluorescence, while the red line 
represents the level of fluorescence indicated for the labeled antibody CD163. The Null PAMS 
did not show any observable level of fluorescence for CD163. There was an observable 
fluorescence for CD169 in Null PAMs. 
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Figure 3.2:In Vitro infection of PAMs measured in units of TCID50 
Comparing WT, hCD163L-1, and Null pig PAM infections in units of TCID50. A and B) 
hCD163L-1 pigs showed one half fold less infectivity compared to WT pigs when compared 
across seven various PRRSV isolates. C) Null PAMs failed to support virus infection.  
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 Figure 3.3:In Vitro infection of PAMs measured in units of TCID50 
From Wells et al. 2017. Comparing HL11 (hCD163L-1) pigs to WT pig in units of TCID50. 
HL11 pigs showed one half fold less infectivity compared to WT pigs when compared across 
seven various PRRSV isolates.  
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Figure 3.4: In Vitro infection of PAMs measured in percent infection 
Comparing hCD163L-1 pigs to WT pig in percentage of PRRSV infection. A) There was no 
infectivity of hCD163L-1 pigs with genotype 1 PRRSV isolates. B) hCD163L-1 pigs showed 
one half fold less infectivity compared to WT pigs when compared across nine various genotype 
2 PRRSV isolates. 
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 Figure 3.5:In vitro infection of PMBC derived macrophages  
WT macrophages demonstrated almost full virus replication, while cells of the hCD163L-1 
genotype displayed slightly less than one third of WT percent infection. Pigs of the Null 
genotype did not support virus replication.  
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Figure 3.6:Images of PBMC derived macrophages infected with VR-2332 and stained with 
Alexafluor 594. 
A) WT PBMCs expressing almost full fluorescence. B) hCD163L-1 PBMCs expressing 
markedly less fluorescence, but is still somewhat observable. C) PBMCs of the Null genotype 
showing no fluorescence. 
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Figure 3.7:Figures of frozen cultured macrophages from PBMCs  
Cultured macrophages from PBMCs that were frozen as a means of potential 
storage/transportability. Windows indicate the number of cells that were counted in the specific 
well. A) Individual percent fluorescence with windows of allotted pig genotypes. B) Average 
percent fluorescence of stained macrophages.  
 
A) 
B) 
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Chapter 4 - Discussions and Conclusion 
The objective of this study was to verify the disease resistance capabilities of 
macrophages derived from genetically edited pigs when exposed to not only one isolate of 
PRRSV, but multiple isolates. Since CD163 was found to serve as the main receptor for PRRSV 
incorporation into the macrophage, many studies have been undergone as an effort to better 
understand the receptor and ways to manipulate it. The manipulation of CD163 was performed 
and successful by utilizing the CRISPR/Cas9 gene editing system (Calvert et al. 2007; 
Whitworth et al. 2013)  
  Previously, an in vivo challenge was performed on WT pigs and pigs that were 
genetically edited with CRISPR/Cas9 technology. Null gene-edited pigs were found to be 
resistant to both genotype 1 and 2 PRRSV isolates. Additionally, it was found that hCD163L-1 
pigs were completely resistant to genotype 1 (European) but not to genotype 2 (North American) 
PRRSV (Wells et al., 2017). The results from this study warranted further investigation of the 
resistance capabilities of Null and hCD163L-1 genotypes.  
The discovery of newfound resistance led to in vitro challenges of PAMs to multiple 
isolates of PRRSV, either from genotype 1 or 2 lineage. Results from the in vitro challenges 
indicated that the Null pig genotype is completely resistant to all PRRSV isolates (both genotype 
1 and 2), while the hCD163L-1 genotype is completely resistant to multiple genotype 1 PRRSV 
isolates, and reduced infection with genotype 2 isolates. (Wells et al., 2017).  However, in vitro 
experiments showing reduced infection of hCD163L-1 PAMs did not reflect the results from the 
in vivo PRRSV challenge. hCD163L-1 pigs infected with the genotype 2 virus had a mean 
viremia like the WT pigs, indicating the reduced of permissiveness of PAMs did not translate 
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back to the pig. There are limitations of deducing in vitro model results back to the live animal, 
and these results have proven correct of these limitations. 
Extraction of PAMS from pigs requires a terminal procedure consisting of lung lavages. 
Upon necropsy, care must be taken to avoid PAM contamination from other bodily fluids or 
tissues. The isolation of PBMCs from whole blood can serve as an alternative option of using 
macrophages for in vitro experiments. Eventual differentiation of macrophages in culture from 
isolated PBMCs do not require the sacrifice of an animal.  
The demonstration of CD163 gene edited pigs, showing no support of infection from 
multiple isolates of PRRSV from either genotype, can infer their potential resistance to a vast 
number of more isolates (Wells et al., 2017). Cell culture models can prove a valuable resource 
for evaluating the pathogenesis of PRRSV and the expression of CD163. Additionally, in vitro 
experiments have the capability of producing results in a more cost effective and timely fashion. 
Procedures for further in vitro investigations regarding the gene edited pig can expand our 
understanding of not only the CD163 receptor, but potentially other genes that have the 
capability of being edited by CRISPR/Cas9 technology. PRRSV resistant pigs emphasizes the 
outstanding opportunity to create a preventative cure for one of the most significant diseases 
affecting the pork industry throughout the globe.  
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